Recommendation of the President – Truqap (capivasertib)

On 7 May 2025, the President of the Agency for Health Technology Assessment and Tariff System issued recommendation No. 56/2025 on the appraisal of drug Truqap (capivasertib) under the B.9.FM drug program. “Treatment of patients with breast cancer (ICD-10: C50)”

Publication in Public Information Bulletin (BIP) >>